skip to navigation skip to content

Business Weekly: Janssen snaps up Cambridge ‘miracle’ antibody startup


XO1, which developed a “miracle” antibody, has been bought by global pharma company Janssen Pharmaceuticals (part of the global company Johnson & Johnson). The Cambridge startup’s CEO is Dr Richard Mason, who’s a member of the Cambridge MBA class of 1999 and a Fellow in Health Management at Cambridge Judge.

Read the full article []